These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26013174)

  • 1. Juvenile animal testing of hydroxypropyl-β-cyclodextrin in support of pediatric drug development.
    De Schaepdrijver L; Mariën D; Rhimi C; Voets M; van Heerden M; Lammens L
    Reprod Toxicol; 2015 Aug; 56():87-96. PubMed ID: 26013174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic and renal toxicities of indomethacin acid, salt form and complexed forms with hydroxypropyl-β-cyclodextrin on Wistar rats after oral administration.
    Ribeiro-Rama AC; Figueiredo IV; Veiga FJ; Castel-Branco MM; Cabrita AM; Caramona MM
    Fundam Clin Pharmacol; 2011 Oct; 25(5):599-607. PubMed ID: 21077942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review.
    Gould S; Scott RC
    Food Chem Toxicol; 2005 Oct; 43(10):1451-9. PubMed ID: 16018907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison in toxicity and solubilizing capacity of hydroxypropyl-β-cyclodextrin with different degree of substitution.
    Li P; Song J; Ni X; Guo Q; Wen H; Zhou Q; Shen Y; Huang Y; Qiu P; Lin S; Hu H
    Int J Pharm; 2016 Nov; 513(1-2):347-356. PubMed ID: 27628782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing a potential in vivo drug-excipient interaction: temporal effects of a modified β-cyclodextrin on the intravenous pharmacokinetics of a model high-affinity drug ligand.
    Mannila A; Morizzi J; Nguyen TT; Charman SA; McIntosh MP; Shackleford DM
    J Pharm Sci; 2012 Sep; 101(9):3381-9. PubMed ID: 22549698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and tissue tolerance of ricobendazole in the presence of hydroxypropyl-beta-cyclodextrin following subcutaneous injection in sheep.
    Wu Z; Tucker IG; Razzak M; Yang L; McSporran K; Medlicott NJ
    Int J Pharm; 2010 Sep; 397(1-2):96-102. PubMed ID: 20621175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutics of 13-cis-retinoic acid (isotretinoin) formulated with modified beta-cyclodextrins.
    Lin HS; Leong WW; Yang JA; Lee P; Chan SY; Ho PC
    Int J Pharm; 2007 Aug; 341(1-2):238-45. PubMed ID: 17482391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nasal powder formulation of glucagon: toxicology studies in animal models.
    Reno FE; Normand P; McInally K; Silo S; Stotland P; Triest M; Carballo D; Piché C
    BMC Pharmacol Toxicol; 2015 Oct; 16():29. PubMed ID: 26502880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of a novel β-cyclodextrin derivative for oral insulin delivery and absorption.
    Zhang L; Zhang Z; Li N; Wang N; Wang Y; Tang S; Xu L; Ren Y
    Int J Biol Macromol; 2013 Oct; 61():494-500. PubMed ID: 23994793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
    McCormack B; Gregoriadis G
    Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tervonen J; Jarho P
    Life Sci; 2006 Mar; 78(17):1911-4. PubMed ID: 16266727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
    Liu J; Qiu L; Gao J; Jin Y
    Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxypropyl-β-cyclodextrin impacts renal and systemic hemodynamics in the anesthetized dog.
    Rosseels ML; Delaunois AG; Hanon E; Guillaume PJ; Martin FD; van den Dobbelsteen DJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):351-9. PubMed ID: 23978386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the impact of sulfobutylether7 -β-cyclodextrin on the liquid chromatography-mass spectrometry analysis of biological samples arising from in vivo pharmacokinetic studies.
    Leong NJ; Prankerd RJ; Shackleford DM; Mcintosh MP
    J Pharm Sci; 2015 Apr; 104(4):1561-2. PubMed ID: 25583633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between epidurally and intrathecally administered sufentanil and bupivacaine in hydroxypropyl-beta-cyclodextrin in the rat.
    Meert TF; Melis W
    Acta Anaesthesiol Belg; 1992; 43(2):79-89. PubMed ID: 1385920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.
    Abdel-Rahman SM; Jacobs RF; Massarella J; Kauffman RE; Bradley JS; Kimko HC; Kearns GL; Shalayda K; Curtin C; Maldonado SD; Blumer JL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2668-73. PubMed ID: 17517842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term parenteral administration of 2-hydroxypropyl-β-cyclodextrin causes bone loss.
    Kantner I; Erben RG
    Toxicol Pathol; 2012 Jul; 40(5):742-50. PubMed ID: 22552390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrin Reduces Intravenous Toxicity of a Model Compound.
    Mantik P; Xie M; Wong H; La H; Steigerwalt RW; Devanaboyina U; Ganem G; Shih D; Flygare JA; Fairbrother WJ; Chakravarty P; Russell D; Fernandez GE; Narang AS
    J Pharm Sci; 2019 Jun; 108(6):1934-1943. PubMed ID: 30639736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of pulmonary absorption of poorly absorbable macromolecules by hydroxypropyl-β-cyclodextrin grafted polyethylenimine (HP-β-CD-PEI) in rats.
    Zhang H; Huang X; Sun Y; Lu G; Wang K; Wang Z; Xing J; Gao Y
    Int J Pharm; 2015 Jul; 489(1-2):294-303. PubMed ID: 25959121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
    Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
    Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.